Northern Trust’s Damora Therapeutics DMRA Stock Holding History

Northern Trust’s Portfolio DMRA Stock Details DMRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.36M	Buy	359,705 +320,823	+825%	+$7.77M	﹤0.01%	2256
2026 Q1	$1.01M	Buy	+38,882	New	+$999K	﹤0.01%	3339
2024 Q3	–	Sell	-1,426	Closed	-$16.9K	–	4426
2024 Q2	$16.9K	Buy	1,426 +604	+73%	+$9.54K	﹤0.01%	4343
2024 Q1	$16K	Hold	822	–	–	﹤0.01%	4358
2023 Q4	$14.8K	Hold	822	–	–	﹤0.01%	4393
2023 Q3	$14.8K	Hold	822	–	–	﹤0.01%	4369
2023 Q2	$51.8K	Hold	822	–	–	﹤0.01%	4217
2023 Q1	$40.9K	Hold	822	–	–	﹤0.01%	4303
2022 Q4	$23.6K	Hold	822	–	–	﹤0.01%	4458
2022 Q3	$39K	Hold	822	–	–	﹤0.01%	4389
2022 Q2	$36K	Buy	822 +62	+8%	+$2.84K	﹤0.01%	4499
2022 Q1	$42K	Hold	760	–	–	﹤0.01%	4570
2021 Q4	$58K	Hold	760	–	–	﹤0.01%	4565
2021 Q3	$68K	Buy	+760	New	+$81.3K	﹤0.01%	4484

Other funds holding DMRA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FIS

FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Jupiter Topco New York $245B AUM

RCP

Remedium Capital Partners Fort Lauderdale, Florida $452M AUM

Northern Trust's DMRA Position: Q2 2026 in Review

Northern Trust increased its Damora Therapeutics (DMRA) stake by 825% in Q2 2026, buying an estimated $7.77M and bringing the position to 359,705 shares worth $9.36M. The position accounts for ﹤0.01% of the portfolio, ranked #2256.

Northern Trust first reported a position in DMRA in Q3 2021 and has held it in 14 quarters since. 104 funds tracked by Wall St. Rank hold DMRA as of Q2 2026.

Northern Trust held 359,705 shares of Damora Therapeutics worth $9.36M as of Q2 2026.
Northern Trust bought 320,823 Damora Therapeutics shares in Q2 2026, an estimated $7.77M.
Damora Therapeutics made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #2256 holding.
Northern Trust first reported a position in Damora Therapeutics in Q3 2021 and has held it in 14 quarters since.
104 funds tracked by Wall St. Rank held Damora Therapeutics as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.